Overview

A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
A study of patient adherence and convenience to immunosuppressive agents in newly liver transplant recipients - a prospective, multi-center, open-labeled, randomized clinical trial for comparison between once-daily early conversion and twice-daily tacrolimus formulation.
Phase:
Phase 4
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborator:
Astellas Pharma Taiwan, Inc.
Treatments:
Immunosuppressive Agents
Tacrolimus